Targeting Gram-negative bacteria
In this project, novel small molecule antibiotics will be developed to target highly resistant Gram-negative bacteria. Gram-negative bacteria can cause various infections such as dermatitis, blood poisoning or pneumonia.
Description
Antibiotic resistance is one of the biggest threats to global health today. This can affect anyone of any age and in any country. This problem is particularly pronounced in Gram-negative bacteria. Therefore, we will develop novel small molecule antibiotics targeting highly resistant Gram-negative bacteria.
Key Data
Projectlead
Prof. Dr. Rainer Riedl, Prof. Dr. Martin Sievers
Deputy Projectlead
Project team
Alexandra Brandenberger, David Frasson, Dr. Ivana Kroslakova, Tobias Wermelinger
Project status
ongoing, started 10/2023
Institute/Centre
Institute of Chemistry and Biotechnology (ICBT)
Funding partner
Innosuisse - Innovationsprojekt
Einsiedlerstrasse 31
8820 Wädenswil